Wuhan Ammunition Life-tech Co.,Ltd.

Wuhan Ammunition Life-tech Co.,Ltd.(abbreviated as Whalt) was established in January 2015. It is a high-tech enterprise focusing on research, development, production and sales of non-invasive early detection products for high-incidence malignant tumors in the world. The company's headquarters is located in Wuhan City, China, supported by a network of six branch offices strategically distributed nationwide.

As a pioneer in tumor early screening and diagnosis, our company has established a globally leading technology platform integrating epigenetics, bioinformatics, materials science, and clinical big data. Guided by our "early, accurate, convenient, and inclusive" product philosophy, we have developed non-invasive detection solutions for high-incidence tumors including digestive, gynecological, and urinary system cancers, as well as pan-cancer screening. These innovations enable truly early, non-invasive, and precise tumor detection, effectively reducing both cancer incidence and mortality rates.